Efficacy and Safety of Emergent Carotid Stenting in the Setting of Acute Ischemic Stroke (S02.002)
CONCLUSIONS: The present data suggest that emergent carotid artery stenting in the setting acute ischemic stroke may be performed with an acceptable level of safety and efficacy.Disclosure: Dr. Al-Mufti has nothing to disclose. Dr. Perkins has received personal compensation for activities with Cardinal Health Bristol-Myers Squibb. Dr. Perkins holds stock and/or stock options in Pfizer. Dr. Perkins has received research support from Daiichi/Scirex, Astra Zeneca, Forest Research/Paion, Novo Nordisk, Sanofi-Aventis, and Garnett McKeen Labs. Dr. Khan has nothing to disclose. Dr. Peeling has nothing to disclose. Dr. Fiorella ha...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Al-Mufti, F., Perkins, C., Khan, I., Peeling, L., Fiorella, D. Tags: S02 Acute Stroke Therapy Source Type: research
Tirofiban-induced acute profound thrombocytopenia after primary angioplasty
We describe a case of acute profound thrombocytopenia due to on tirofiban treatment in a patient who underwent primary angioplasty. (Source: Asian Cardiovascular and Thoracic Annals)
Source: Asian Cardiovascular and Thoracic Annals - February 1, 2013 Category: Cardiology Authors: Dursunoglu, D., Taskoylu, O., Gur, S., Sari, I. Tags: Cardiovascular Source Type: research
Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention
Conclusions.The combination of pharmacologic and mechanic antithrombotic treatment during pPCI was associated with better 1‐year clinical outcome. © 2013 Wiley Periodicals, Inc. (Source: Catheterization and Cardiovascular Interventions)
Source: Catheterization and Cardiovascular Interventions - January 29, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Stylianos A. Pyxaras, Fabio Mangiacapra, Katia Verhamme, Luigi Di Serafino, Frederic De Vroey, Gabor Toth, Andrea Perkan, Alessandro Salvi, Jozef Bartunek, Bernard De Bruyne, William Wijns, Gianfranco Sinagra, Emanuele Barbato Tags: Original Study Source Type: research
Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention
Background: The impact of diabetes in patients with acute myocardial infarction (AMI) treated with primary percutaneous coronary intervention (PCI) is unclear. The benefit of abciximab in this subset of patients remains controversial.
Methods and results: Three hundred and twenty-seven consecutive and unselected patients with acute AMI treated with primary PCI were included in our single-center retrospective registry, 103 diabetic (31%) and 224 nondiabetic (69%). Abciximab was given at the physician's discretion. Diabetic patients were older (mean age 68.5 ± 11 vs. 65 ± 12 years; P = 0.009), had an increased ...
Source: Journal of Cardiovascular Medicine - January 10, 2013 Category: Cardiology Tags: Original articles: Coronary artery disease Source Type: research
